Research & Innovation 2021

John Davis

 John Davis
John Davis
Oxford ARUK DDI
Speaker

Presentations at Research & Innovation 2021

Wed24  Feb10:30am(35 mins)
Chairing

Session: Seeking novel drug targets for the Discovery pipeline
Room: Conference Hall

Profile of John Davis

John is a biochemist by training with a PhD from the University of Cambridge. Following postdoctoral training at the Ludwig Institute (Middlesex) and the Salk Institute, John joined GlaxoSmithKline where he led a variety of non-clinical pharmacology research departments for pain and neurodegenerative diseases. In 2010, John and colleagues formed the spinout company Convergence Pharmaceuticals which he later left to become Director of Discovery for Selcia Ltd. and a cofounder of Cypralis Ltd.. Since 2015 John has been leading the Alzheimer’s Research UK Drug Discovery Institute based in the University of Oxford. John has 20+ years of drug discovery expertise from target to phase IIa and has helped steer a dozen drug candidates into clinical development and to four positive proof of concepts.
Email
Please login to send a Private Message

Hosted By
ELRIG
The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Web Site Find us on Facebook Follow us on Twitter

Get the App
Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Eventflo Home
copyright ELRIG, eventflo, Labhoo Ltd 2003-2020